GB9310635D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9310635D0
GB9310635D0 GB939310635A GB9310635A GB9310635D0 GB 9310635 D0 GB9310635 D0 GB 9310635D0 GB 939310635 A GB939310635 A GB 939310635A GB 9310635 A GB9310635 A GB 9310635A GB 9310635 D0 GB9310635 D0 GB 9310635D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939310635A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB939310635A priority Critical patent/GB9310635D0/en
Publication of GB9310635D0 publication Critical patent/GB9310635D0/en
Priority to ZA943494A priority patent/ZA943494B/xx
Priority to TW083104441A priority patent/TW279866B/zh
Priority to CZ953051A priority patent/CZ305195A3/cs
Priority to AU69287/94A priority patent/AU6928794A/en
Priority to HU9503321A priority patent/HUT73790A/hu
Priority to SK1424-95A priority patent/SK142495A3/sk
Priority to JP7500181A priority patent/JPH08510455A/ja
Priority to CA002162921A priority patent/CA2162921A1/en
Priority to EP94917647A priority patent/EP0699196A1/en
Priority to PCT/EP1994/001613 priority patent/WO1994027989A1/en
Priority to PL94311702A priority patent/PL311702A1/xx
Priority to CN94192683A priority patent/CN1126473A/zh
Priority to IL10970394A priority patent/IL109703A0/xx
Priority to PE1994255110A priority patent/PE31195A1/es
Priority to OA60742A priority patent/OA10195A/en
Priority to NO954681A priority patent/NO954681D0/no
Priority to FI955587A priority patent/FI955587A0/fi
Priority to BG100154A priority patent/BG100154A/xx
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB939310635A 1993-05-21 1993-05-21 Chemical compounds Pending GB9310635D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds
ZA943494A ZA943494B (en) 1993-05-21 1994-05-02 Chemical compounds
TW083104441A TW279866B (cs) 1993-05-21 1994-05-17
AU69287/94A AU6928794A (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity
CA002162921A CA2162921A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17, 20-lyase-inhibiting activity
CN94192683A CN1126473A (zh) 1993-05-21 1994-05-19 化学组合物
HU9503321A HUT73790A (en) 1993-05-21 1994-05-19 Carbazole derivatives, pharmaceutical compositions containing them and process for proucing them
SK1424-95A SK142495A3 (en) 1993-05-21 1994-05-19 Carbazole derivatives, process for preparing the same, pharmaceutical compositions containing the same and their use
JP7500181A JPH08510455A (ja) 1993-05-21 1994-05-19 17,20―リアーゼ阻害活性を有するカルバゾール誘導体
CZ953051A CZ305195A3 (en) 1993-05-21 1994-05-19 Carbazole derivatives, process of their preparation, their use and pharmaceutical compositions containing thereof
EP94917647A EP0699196A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity
PCT/EP1994/001613 WO1994027989A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity
PL94311702A PL311702A1 (en) 1993-05-21 1994-05-19 Chemical compounds
IL10970394A IL109703A0 (en) 1993-05-21 1994-05-20 Substituted carbazole derivatives, processes for their preparation and pharmaceutical compositions containing them
PE1994255110A PE31195A1 (es) 1993-05-21 1994-11-18 Derivado de carbazol sustituido, proceso para su preparacion y composicion farmaceutica que lo contiene
OA60742A OA10195A (en) 1993-05-21 1995-11-17 Carbazole derivatives with 17 20-lyase-inhibiting activity
NO954681A NO954681D0 (no) 1993-05-21 1995-11-20 Kjemiske forbindelser
FI955587A FI955587A0 (fi) 1993-05-21 1995-11-20 Kemialliset yhdisteet
BG100154A BG100154A (en) 1993-05-21 1995-11-21 Carbazole derivatibes having inhibiting effect to 17,20-lyase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9310635D0 true GB9310635D0 (en) 1993-07-07

Family

ID=10736007

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939310635A Pending GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds

Country Status (19)

Country Link
EP (1) EP0699196A1 (cs)
JP (1) JPH08510455A (cs)
CN (1) CN1126473A (cs)
AU (1) AU6928794A (cs)
BG (1) BG100154A (cs)
CA (1) CA2162921A1 (cs)
CZ (1) CZ305195A3 (cs)
FI (1) FI955587A0 (cs)
GB (1) GB9310635D0 (cs)
HU (1) HUT73790A (cs)
IL (1) IL109703A0 (cs)
NO (1) NO954681D0 (cs)
OA (1) OA10195A (cs)
PE (1) PE31195A1 (cs)
PL (1) PL311702A1 (cs)
SK (1) SK142495A3 (cs)
TW (1) TW279866B (cs)
WO (1) WO1994027989A1 (cs)
ZA (1) ZA943494B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009157A1 (en) * 1993-09-30 1995-04-06 Yamanouchi Pharmaceutical Co., Ltd. Azole derivative and pharmaceutical composition thereof
WO1996014090A1 (en) * 1994-11-07 1996-05-17 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
EP0820989A4 (en) * 1995-03-01 1998-05-06 Yamanouchi Pharma Co Ltd IMIDAZOLE DERIVATIVES AND MEDICINAL COMPOSITION BASED ON SAID DERIVATIVES
DE69810760T2 (de) * 1997-02-21 2003-11-20 Takeda Chemical Industries, Ltd. Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung
DE60119963T2 (de) 2000-11-17 2006-10-05 Takeda Pharmaceutical Co. Ltd. Imidazol derivate, ihre herstellung und ihre verwendung
ATE502030T1 (de) 2000-11-20 2011-04-15 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
EP1348706B1 (en) 2000-12-08 2009-08-19 Takeda Pharmaceutical Company Limited Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
WO2007002181A2 (en) * 2005-06-24 2007-01-04 Eli Lilly And Company Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
GB0525323D0 (en) * 2005-12-13 2006-01-18 Sterix Ltd Compound
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
CN100586932C (zh) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 抗肿瘤化合物及其制备方法
EA021011B1 (ru) 2009-06-26 2015-03-31 Новартис Аг 1,3-ДИЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ИМИДАЗОЛИДИН-2-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ Cyp 17
JP5964756B2 (ja) 2010-02-04 2016-08-03 ラジウス ヘルス,インコーポレイテッド 選択的アンドロゲン受容体モジュレーター
PT2568806T (pt) 2010-05-12 2016-08-05 Radius Health Inc Regimes terapêuticos
WO2012018948A2 (en) 2010-08-04 2012-02-09 Pellficure Pharmaceuticals, Inc. Novel treatment of prostate carcinoma
JP2013537210A (ja) 2010-09-16 2013-09-30 ノバルティス アーゲー 17α−ヒドロキシラーゼ/C17,20−リアーゼ阻害剤
WO2012047617A1 (en) 2010-09-28 2012-04-12 Radius Health, Inc. Selective androgen receptor modulators
CN103649073B (zh) 2011-04-28 2016-04-13 诺瓦提斯公司 17α-羟化酶/C17,20-裂合酶抑制剂
US9492460B2 (en) * 2013-02-27 2016-11-15 Bristol-Myers Squibb Company Carbazole compounds useful as bromodomain inhibitors
US20160022606A1 (en) 2013-03-14 2016-01-28 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
LT3122426T (lt) 2014-03-28 2023-03-10 Duke University Krūties vėžio gydymas, naudojant selektyvius estrogenų receptorių moduliatorius
EP3191087A1 (en) 2014-09-12 2017-07-19 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
PL3474841T3 (pl) 2016-06-22 2022-07-11 Ellipses Pharma Ltd Sposoby leczenia nowotworu złośliwego piersi ar+
AU2017350690A1 (en) 2016-10-24 2019-06-13 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
KR102557321B1 (ko) 2017-01-05 2023-07-18 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
OA10195A (en) 1996-12-18
EP0699196A1 (en) 1996-03-06
FI955587A7 (fi) 1995-11-20
SK142495A3 (en) 1996-06-05
FI955587A0 (fi) 1995-11-20
ZA943494B (en) 1995-01-23
WO1994027989A1 (en) 1994-12-08
CN1126473A (zh) 1996-07-10
NO954681L (no) 1995-11-20
CZ305195A3 (en) 1996-06-12
BG100154A (en) 1996-07-31
HUT73790A (en) 1996-09-30
HU9503321D0 (en) 1996-01-29
NO954681D0 (no) 1995-11-20
TW279866B (cs) 1996-07-01
PL311702A1 (en) 1996-03-04
JPH08510455A (ja) 1996-11-05
CA2162921A1 (en) 1994-12-08
AU6928794A (en) 1994-12-20
IL109703A0 (en) 1994-08-26
PE31195A1 (es) 1995-10-18

Similar Documents

Publication Publication Date Title
GB9304618D0 (en) Chemical compounds
GB9315017D0 (en) Chemical compounds
GB9305469D0 (en) Chemical compounds
ZA943494B (en) Chemical compounds
GB2280677B (en) Chemical compounds
GB9305509D0 (en) Chemical compounds
GB9305523D0 (en) Chemical compounds
GB9305510D0 (en) Chemical compounds
GB9305459D0 (en) Chemical compounds
GB9305806D0 (en) Chemical compounds
GB9306941D0 (en) Chemical compounds
GB9314977D0 (en) Chemical compounds
GB9300558D0 (en) Chemical compounds
GB9314978D0 (en) Chemical compounds
GB9303903D0 (en) Chemical compounds
GB9301092D0 (en) Chemical compounds
GB9303573D0 (en) Chemical compounds
GB9302844D0 (en) Chemical compounds
GB9302801D0 (en) Chemical compounds
GB9300882D0 (en) Chemical compounds
GB9303572D0 (en) Chemical compounds
GB9300557D0 (en) Chemical compounds
GB9304530D0 (en) Chemical compounds
GB9422619D0 (en) Chemical compounds
GB9304499D0 (en) Chemical compounds